These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6178922

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH, Mailliard JA, Suman VJ, Edmonson JH, Creagan ET, Nair S, Levitt R, Kugler JW.
    Cancer; 2002 Apr 15; 94(8):2224-31. PubMed ID: 12001121
    [Abstract] [Full Text] [Related]

  • 3. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
    Jahnke V.
    HNO; 1980 Dec 15; 28(12):405-8. PubMed ID: 6161913
    [Abstract] [Full Text] [Related]

  • 4. [Chemotherapy of advanced head and neck cancer with a combination of bleomycin, vincristine, methotrexate and hydroxyuree or cis-dichloro-diamino-platinium. Analysis of local and general parameters of prognosis (author's transl)].
    Pouillart P, Palangie T, Garcia-Giralt E, Jouve M, Bataini JP, Jaulerry M, Brugère J, Asselin B.
    Bull Cancer; 1980 Dec 15; 67(3):269-80. PubMed ID: 6157447
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy of squamous cell carcinoma of the head and neck.
    Greenberg BR.
    Ariz Med; 1985 Jul 15; 42(7):411-7. PubMed ID: 2412534
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, Lacave AJ, van Hoesel Q, Cervantes A, Bolis G, Namer M, Lhommé C, Guastalla JP, Nooij MA, Poveda A, Scotto di Palumbo V, Vermorken JB.
    Gynecol Oncol; 2001 Jun 15; 81(3):348-54. PubMed ID: 11371121
    [Abstract] [Full Text] [Related]

  • 10. [Initial experiences with a new treatment protocol in otorhinolaryngologic cancers].
    Lehnert M, Jakse R, Scherlacher A, Tschech G.
    Acta Med Austriaca Suppl; 1979 Jun 15; 6():337-9. PubMed ID: 95541
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
    Giatromanolaki A, Koukourakis M, Zaramboukas T, Skordalaki A, Arapantoni P, Georgoulias V, Fountzilas G.
    Anticancer Res; 1998 Jun 15; 18(6B):4685-92. PubMed ID: 9891541
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
    Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC, Harris AL.
    Clin Cancer Res; 2000 Feb 15; 6(2):381-9. PubMed ID: 10690514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Results of primary chemotherapy in 44 patients with advanced squamous cell carcinoma in the area of the head and neck].
    von Heyden HW, Schröder M, Scherpe A, Stennert E, Beyer JH, Nagel GA, Hoffmann H, Schneider B.
    HNO; 1984 Nov 15; 32(11):454-9. PubMed ID: 6210278
    [Abstract] [Full Text] [Related]

  • 18. Preoperative sequential chemotherapy in locally advanced squamous cell carcinoma of the head and neck.
    Faivre S, Marti A, Rixe O, Janot F, Julieron M, Gatineau M, Temam S, Armand JP, Domenge C, Luboinski B, Raymond E.
    Head Neck; 2005 Apr 15; 27(4):311-9. PubMed ID: 15700290
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R, Hornedo J, Colomer R, Mendiola C, Brandariz A, Sevilla E, Alvarez-Vicent J, Cortés-Funes H.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.